Mokari Atabak

Chief Financial OfficerCORCEPT THERAPEUTICS INC (CORT) · full profile →Form 4 · filed Jul 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.5M
Net Open-Market Flow
-$3.5M
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2026Option exercise(M)16K$19.26$305K32K
Jul 15, 2026Option exercise(M)24K$23.06$557K56K
Jul 15, 2026Sell(S)8K$86.78$687K48K
Jul 15, 2026Sell(S)28K$87.89$2.5M20K
Jul 15, 2026Sell(S)4K$88.30$311K16K
Jul 15, 2026Sell(S)101$89.43$9K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2026Option exercise(M)16K$04K
Jul 15, 2026Option exercise(M)24K$0176K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-308058) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about CORT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-26-308058"
Ask your agent
Use Arkolith to summarize insider buying and selling at CORCEPT THERAPEUTICS INC
over the last 90 days and cite the filings.